Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of DSXS in mild to moderate plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• DSXS

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2018-12-10